Unlocking Breakthrough Antimicrobial Solutions for Global Health

Delivering dual-action therapies that overcome drug resistance, eradicate biofilms, and revolutionize care for patients facing chronic and life-threatening infections.

Global Crisis of Infection and Inflammation

Bacterial biofilms drive relentless inflammation and severe infections

Every 3s

A Life is Lost Globally Due to Sepsis

1.5m Deaths

Directly linked to antimicrobial resistance annually

5m Deaths

Indirectly contributed to by antimicrobial resistance each year

Experience the Future of Infection Treatment

See how our cutting-edge technology is transforming healing and tackling drug-resistant infections.

Explore Our Technology

Advancing Antimicrobial Solutions for Critical Infections

Innovative Pipeline

Medical Devices

Discovery

Validation

Biocompatibility

Approval

Commercialization

ComBatic™ Antimicrobial Wound Care

Therapeutics

Discovery

Pre-Clinical

Phase I

Phase II

Phase III

COMB-NEBTM for Respiratory Infection

Therapeutics

Discovery

Pre-Clinical

Phase I

Phase II

Phase III

MHC-200 for Systemic infection

Together, We Can Change the Future of Infection Treatment

Collaboration fuels discovery. Let’s push the boundaries of science, tackle antimicrobial resistance, and create lasting impact together

Let’s Connect & Innovate

Driven by Science, Focused on Impact

About us

Cutting-Edge R&D

Developing novel, safe antibacterial agents with low resistance potential.

Award-Winning Innovation

Recognized globally for scientific excellence and industry impact.

Learn More About Our Mission

Science-Backed & Validated

Tested in FDA and Health Canada-approved labs for safety and efficacy.

Driving Global Change

Committed to transforming infection treatment and improving patient outcomes.